31,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
16 °P sammeln
  • Broschiertes Buch

Pentoxifylline is a safe and well-tolerated methylxanthine derivative with several pharmacological properties that made a well-established therapy for the treatment of intermittent claudication associated with peripheral vascular diseases. It can reduce blood and plasma viscosity, and plasma fibrinogen while promoting fibrinolysis. It can improve blood filterability by enhancing erythrocyte distensibility and reduce neutrophil activation. Pentoxifylline also has anti-inflammatory effects and was reported to have the potential for retarding the progression of atherosclerosis. The aim of this…mehr

Produktbeschreibung
Pentoxifylline is a safe and well-tolerated methylxanthine derivative with several pharmacological properties that made a well-established therapy for the treatment of intermittent claudication associated with peripheral vascular diseases. It can reduce blood and plasma viscosity, and plasma fibrinogen while promoting fibrinolysis. It can improve blood filterability by enhancing erythrocyte distensibility and reduce neutrophil activation. Pentoxifylline also has anti-inflammatory effects and was reported to have the potential for retarding the progression of atherosclerosis. The aim of this book is to describe pentoxifylline research progress in various fields of medicine including nephrology, cardiology, andrology, hepatology, neuropsychiatry, pulmonology, and ophthalmology.
Autorenporträt
Aamir Jalal Al-Mosawi è medico consulente presso il Centro nazionale di formazione e sviluppo del Ministero della Salute iracheno e la Città medica di Baghdad. È stato capo della sede irachena del gruppo internazionale di scienziati Copernicus (2006-ottobre 2020). È anche membro del consiglio consultivo dell'Associazione internazionale dei collegi medici (IAMC), dal 2008.